Department of Urology
Sarah Psutka has not added Biography.
If you are Sarah Psutka and would like to personalize this page please email our Author Liaison for assistance.
Unraveling Associations Between Occupation and Bladder Cancer Aggressiveness: Describing the Landscape.
European urology focus 09, 2018 | Pubmed ID: 30154044
Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer.
Bladder cancer (Amsterdam, Netherlands) Oct, 2018 | Pubmed ID: 30417052
MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement.
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme Aug, 2019 | Pubmed ID: 30615474
Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting Jan, 2019 | Pubmed ID: 31099657
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.
European urology oncology 09, 2018 | Pubmed ID: 31100250
Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication.
The Journal of urology 11, 2019 | Pubmed ID: 31112106
Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen Levels.
Journal of the National Cancer Institute 04, 2020 | Pubmed ID: 31225597
Reply by Authors.
The Journal of urology 11, 2019 | Pubmed ID: 31364930
Xanthogranulomatous Pyelonephritis With Direct Extension Into the Liver.
The American journal of medicine 09, 2020 | Pubmed ID: 31991112
Risk stratification metrics for bladder cancer: Comprehensive Geriatric Assessments.
Urologic oncology 09, 2020 | Pubmed ID: 32037198
Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients.
American journal of therapeutics May, 2020 | Pubmed ID: 32384317
Personalizing preoperative risk stratification and refining patient selection for cytoreductive nephrectomy in metastatic renal cell carcinoma.
Cancer Sep, 2020 | Pubmed ID: 32515836
Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of risk.
Urologic oncology 09, 2020 | Pubmed ID: 32600927
Assessing Contemporary Trends in Female Speakership within Urologic Oncology.
Urology Aug, 2020 | Pubmed ID: 32798517
Prostate cancer presentation, treatment selection, and outcomes among men with HIV/AIDS: A clinical stage, race, and age-matched contemporary analysis.
Urologic oncology 01, 2021 | Pubmed ID: 32843291
Women in Leadership in Urology: The Case for Increasing Diversity and Equity.
Urology Sep, 2020 | Pubmed ID: 32961220
Quantification of body composition in renal cell carcinoma patients: Comparing computed tomography and magnetic resonance imaging measurements.
European journal of radiology Nov, 2020 | Pubmed ID: 33010681
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program.
Clinical genitourinary cancer Oct, 2020 | Pubmed ID: 33160889
Female Authorship Trends in Urology During the COVID-19 Pandemic.
European urology 02, 2021 | Pubmed ID: 33250302
Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015.
Urology Mar, 2021 | Pubmed ID: 33373709
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
Urologic oncology Feb, 2021 | Pubmed ID: 33551249
Advances in the Characterization of Clear Cell Papillary Renal Cell Carcinoma: Identifying the Sheep in Wolf's Clothing.
European urology Apr, 2021 | Pubmed ID: 33579573
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados